Your browser doesn't support javascript.
loading
Recommendations for COPD management in Central and Eastern Europe.
Valipour, Arschang; Aisanov, Zaurbek; Avdeev, Sergey; Koblizek, Vladimir; Kocan, Ivan; Kopitovic, Ivan; Lupkovics, Gergely; Man, Milena; Bukovskis, Maris; Tudoric, Neven; Vukoja, Marija; Naumnik, Wojciech; Yanev, Nikolay.
Afiliação
  • Valipour A; Department of Respiratory and Critical Care Medicine, Karl-Landsteiner-Institute for Lung Research and Pulmonary Oncology, Vienna Health Care Group, Vienna, Austria.
  • Aisanov Z; Department of Pulmonology, Pirogov Russian State National Research Medical University, Moscow, Russia.
  • Avdeev S; Pulmonology Department, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.
  • Koblizek V; Department of Pneumology, Faculty of Medicine in Hradec Kralove, Charles University Hospital, Hradec Kralove, Czech Republic.
  • Kocan I; University Hospital Martin, Jessenius Faculty of Medicine, Commenius University, Martin, Slovakia.
  • Kopitovic I; Department for Respiratory Pathophysiology and Sleep Disordered Breathing, The Institute for Pulmonary Diseases of Vojvodina, Sremska Kamenica, Serbia.
  • Lupkovics G; Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia.
  • Man M; Adult Pulmonary Department, Institute for Pulmonary Diseases, Törökbálint, Hungary.
  • Bukovskis M; Pulmonology Department, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
  • Tudoric N; Department of Internal Diseases, Faculty Medicine, University of Latvia, Riga, Latvia.
  • Vukoja M; School of Medicine, University of Zagreb, Zagreb, Croatia.
  • Naumnik W; Department for Respiratory Pathophysiology and Sleep Disordered Breathing, The Institute for Pulmonary Diseases of Vojvodina, Sremska Kamenica, Serbia.
  • Yanev N; Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia.
Expert Rev Respir Med ; 16(2): 221-234, 2022 02.
Article em En | MEDLINE | ID: mdl-35001780
Chronic obstructive pulmonary disease (COPD) is a common disease of the lungs. It causes symptoms such as breathlessness, cough, and production of phlegm. In people with COPD, these symptoms often reduce the quality of their lives. From time to time, symptoms may get worse in people with the disease. This worsening is known as 'exacerbation'. Exacerbations of COPD can be so bad that they lead to hospital admissions. The Global Initiative for Chronic Obstructive Lung Disease (GOLD) regularly gives advice to doctors around the world. This can help them to provide their patients with the best possible treatment for COPD. However, people with the disease and healthcare systems vary from country to country. This means that the guidance may need to be adjusted to the needs and available resources of different regions. This review looks at how COPD is treated in Central and Eastern Europe. We suggest how to adapt the GOLD recommendations to best suit the Central and Eastern European region.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença Pulmonar Obstrutiva Crônica Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença Pulmonar Obstrutiva Crônica Idioma: En Ano de publicação: 2022 Tipo de documento: Article